Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-03-26 Lawrence Thomas R Director Grant or award +1,000 $4.78 $5K 192,354
2013-03-26 KAZIMI A J Chairman and CEO Grant or award +50,000 $4.78 $239K 5,564,342
2013-03-26 JACOBS JOEY A Director Grant or award +1,000 $4.78 $5K 53,000
2013-03-26 Griggs Jonathan Director Grant or award +1,000 $4.78 $5K 3,945
2013-03-26 Greene Rick Scott Chief Financial Officer Grant or award +6,000 $4.78 $29K 39,000
2013-03-26 Edwards Robert Director Grant or award +1,000 $4.78 $5K 416,569
2013-03-26 Cearnal Martin E Sr VP/Chief Commercial Officer Grant or award +6,000 $4.78 $29K 124,700
2013-03-26 Bernard Gordon R Director Grant or award +1,000 $4.78 $5K 113,729
2013-03-26 Bernard Gordon R Director Grant or award +1,000 $4.78 $5K 113,729

Page 207 of 207 · 4,129 trades